3.2 Liver Cirrhosis & Portal Hypertension
Key Takeaways
- Hepatic stellate cell (Ito cell) activation into collagen-producing myofibroblasts in the space of Disse represents the central cellular pathway in liver cirrhosis development.
- Portal hypertension is defined by a Hepatic Venous Pressure Gradient (HVPG) >5 mmHg; clinical manifestations (varices, ascites) emerge when HVPG exceeds 10 mmHg.
- Child-Pugh score assesses cirrhosis prognosis using 5 parameters: Serum Bilirubin, Serum Albumin, INR/PT, Ascites, and Hepatic Encephalopathy.
- Primary prophylaxis for esophageal varices in high-risk patients consists of non-selective beta-blockers (propranolol, nadolol, carvedilol) or endoscopic variceal ligation (EVL).
- Spontaneous Bacterial Peritonitis (SBP) is diagnosed by an ascitic fluid absolute polymorphonuclear (PMN) leukocyte count >=250/mm³ and requires immediate IV 3rd generation cephalosporin plus albumin infusion.
Liver Cirrhosis & Portal Hypertension
Liver cirrhosis is defined histologically as diffuse hepatic fibrosis accompanied by structurally abnormal regenerative nodule formation. It represents the common final pathway of chronic inflammatory liver diseases (e.g., chronic hepatitis B/C, alcohol-associated liver disease, non-alcoholic steatohepatitis/MASH). In UPSC CMS examinations, questions regularly test the cellular mechanism of fibrogenesis, hemodynamic thresholds of portal hypertension, Child-Pugh and MELD scoring systems, and the management of decompensations.
Pathophysiology of Hepatic Fibrosis & Portal Hypertension
1. Cellular Mechanism of Fibrogenesis
- Under normal conditions, Hepatic Stellate Cells (Ito cells) reside in the space of Disse (the extracellular area between hepatocytes and sinusoidal endothelial cells) and function as the primary storage site for Vitamin A (retinoid ester).
- Upon chronic hepatocyte injury, reactive oxygen species (ROS) and inflammatory cytokines (predominantly Transforming Growth Factor-beta1 [TGF-$\beta1$] and PDGF) activate quiescent stellate cells.
- Activated stellate cells transdifferentiate into proliferate, contractile myofibroblasts, losing Vitamin A droplets and secreting massive amounts of Type I and Type III collagen into the space of Disse.
- This leads to capillarization of hepatic sinusoids (loss of endothelial fenestrations), markedly increasing intrahepatic vascular resistance.
2. Hemodynamics of Portal Hypertension
Portal Hypertension is evaluated hemodynamically via the Hepatic Venous Pressure Gradient (HVPG), calculated as:
| HVPG Value | Clinical Significance |
|---|---|
| Normal | 1–5 mmHg |
| Portal Hypertension | $>5\text{ mmHg}$ |
| Clinically Significant Portal HTN (CSPH) | $\ge 10\text{ mmHg}$ (Threshold for varices formation and ascites development) |
| Variceal Rupture Threshold | $\ge 12\text{ mmHg}$ (High risk of acute active variceal hemorrhage) |
Prognostic Classification Systems
Child-Pugh Scoring System (Child-Turcotte-Pugh)
Evaluates surgical risk and 1–2 year survival in cirrhosis using 5 variables (3 biochemical, 2 clinical):
| Parameter | 1 Point | 2 Points | 3 Points |
|---|---|---|---|
| Total Bilirubin (mg/dL) | $<2.0$ | 2.0–3.0 | $>3.0$ |
| Serum Albumin (g/dL) | $>3.5$ | 2.8–3.5 | $<2.8$ |
| INR (or PT prolongation) | $<1.7$ ($<4\text{ s}$) | 1.7–2.3 (4–6 s) | $>2.3$ ($>6\text{ s}$) |
| Ascites | None | Mild / Controlled by diuretics | Moderate to Severe / Refractory |
| Hepatic Encephalopathy | None | Grade I–II (Mild) | Grade III–IV (Severe) |
- Child-Pugh Class A: 5–6 points (Well-compensated; 100% 1-year survival)
- Child-Pugh Class B: 7–9 points (Significant functional compromise; 80% 1-year survival)
- Child-Pugh Class C: 10–15 points (Decompensated; 45% 1-year survival)
MELD-Na Score (Model for End-Stage Liver Disease)
Utilized for organ allocation in liver transplantation. Calculated using logarithmic equations of four objective serum variables: Bilirubin, Serum Creatinine, INR, and Serum Sodium.
Complications of Portal Hypertension & Management
1. Esophageal & Gastric Varices
- Primary Prophylaxis (Prevention of First Bleed): Indicated in patients with medium/large varices or small varices with red wale markings / Child-Pugh C.
- Non-selective $\beta$-blockers (Propranolol, Nadolol, or Carvedilol): Reduce portal inflow via $\beta_1$-adrenergic blockade (decreased cardiac output) and $\beta_2$-blockade (unopposed $\alpha_1$ vasoconstriction of splanchnic circulation).
- Endoscopic Variceal Ligation (EVL): Preferred if $\beta$-blockers are contraindicated or non-tolerated.
- Acute Variceal Bleed Protocol:
- Vasoactive therapy: Terlipressin (synthetic vasopressin analog; selective splanchnic vasoconstrictor), Somatostatin, or Octreotide given immediately.
- Prophylactic IV Antibiotics: Ceftriaxone 1g IV daily for 7 days (reduces bacterial translocation, SBP risk, rebleeding, and mortality).
- Urgent EGD within 12 hours: Perform EVL.
- Rescue Therapy: Transjugular Intrahepatic Portosystemic Shunt (TIPS) creates a low-resistance conduit between the hepatic vein and portal vein branch, reducing HVPG below 12 mmHg.
2. Ascites & Spontaneous Bacterial Peritonitis (SBP)
- Diagnostic Evaluation of Ascites: Paracentesis with Serum-Ascites Albumin Gradient (SAAG) calculation:
- SAAG $\ge 1.1\text{ g/dL}$ (High SAAG): Indicates Portal Hypertension (e.g., Cirrhosis, Cardiac ascites, Budd-Chiari syndrome).
- SAAG $< 1.1\text{ g/dL}$ (Low SAAG): Non-portal hypertension etiologies (e.g., Peritoneal carcinomatosis, Tuberculous peritonitis, Nephrotic syndrome, Pancreatitis).
- Spontaneous Bacterial Peritonitis (SBP):
- Bacterial infection of ascitic fluid without an intra-abdominal surgically treatable source of infection (most common organisms: E. coli, Klebsiella pneumoniae, Pneumococcus).
- Diagnostic criteria: Ascitic fluid Polymorphonuclear (PMN) leukocyte count $\ge 250\text{ cells/mm}^3$ ($0.25 \times 10^9/\text{L}$).
- Treatment: IV 3rd generation cephalosporin (Cefotaxime 2g IV q8h or Ceftriaxone) PLUS IV Albumin ($1.5\text{ g/kg}$ on Day 1 and $1.0\text{ g/kg}$ on Day 3) to preserve renal perfusion and prevent Type 1 Hepatorenal Syndrome.
3. Hepatic Encephalopathy (HE)
- Reversible neuropsychiatric impairment caused by accumulation of gut-derived neurotoxins (chiefly ammonia [$\text{NH}_3$]) bypassing hepatic clearance due to portosystemic shunting and hepatocellular insufficiency.
- Precipitating Factors: GI bleeding, infection/SBP, constipation, hypokalemic metabolic alkalosis, overuse of sedatives, hyponatremia.
- West Haven Criteria: Grade I (trivial lack of awareness, euphoria/anxiety), Grade II (lethargy, disorientation, asterixis / flapping tremor), Grade III (somnolence, stupor, gross disorientation), Grade IV (coma).
- Treatment:
- Lactulose (First-line): Synthetic non-absorbable disaccharide converted by colonic flora into lactic and acetic acids. Acidifies colonic lumen ($\text{pH} < 5.0$), converting diffusable $\text{NH}_3$ into non-absorbable ammonium ($\text{NH}_4^+$) ion ("ammonia trapping"). Promotes osmotic catharsis (titrate to 2–3 soft stools/day).
- Rifaximin (Second-line / Add-on): Non-absorbable oral antibiotic (550 mg BID) that eliminates ammoniagenic gut bacteria.
4. Hepatorenal Syndrome (HRS)
- Functional renal failure in advanced cirrhosis caused by extreme splanchnic arterial vasodilation $\rightarrow$ severe renal vasoconstriction.
- Diagnostic Criteria: Cirrhosis with ascites, serum creatinine $>1.5\text{ mg/dL}$, no response after 48 hours of diuretic withdrawal and IV albumin expansion ($1\text{ g/kg/day}$), absence of shock, proteinuria $<500\text{ mg/day}$, and no parenchymal renal disease.
- Treatment: Terlipressin IV + Albumin IV; definitive treatment is orthotopic liver transplantation.
Which of the following cellular events represents the primary step in the pathogenesis of hepatic fibrosis in cirrhosis?
A 54-year-old male with alcoholic cirrhosis is evaluated for abdominal pain and low-grade fever. Paracentesis yields turbid ascitic fluid. Analysis reveals an albumin concentration of 0.6 g/dL (serum albumin 3.2 g/dL) and a total cell count of 850 cells/mm³ with 70% polymorphonuclear (PMN) leukocytes. What is the diagnosis and initial management?
In the Child-Pugh classification of liver cirrhosis severity, which set of 5 clinical and laboratory parameters is utilized?
A 48-year-old female with cirrhosis due to chronic Hepatitis B undergoes screening EGD, which demonstrates large esophageal varices with red wale markings. She has no history of variceal bleeding. Which of the following is the most appropriate primary prophylactic intervention?